Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | MPO | P05164 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | RORC | P51449 | 1/20 | 0.48 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CTSV | O60911 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3141636 | 0.98 | ALDH1A1 (0.58) | ALDH1A1TDP1CYP3A4ALOX15MPO | |
| SCHEMBL30362211 | 0.88 | ALDH1A1 (0.54) | ALDH1A1TDP1CYP3A4ALOX15MPO | |
| SCHEMBL4433793 | 0.88 | ALDH1A1 (0.54) | ALDH1A1TDP1CYP3A4ALOX15MPO | |
| SCHEMBL5182501 | 0.87 | KMT2A (0.59) | ALDH1A1TDP1CYP3A4ALOX15MAPT | |
| SCHEMBL20568110 | 0.87 | ALDH1A1 (0.48) | ALDH1A1TDP1CYP3A4ALOX15MPO | |
| SCHEMBL3141628 | 0.87 | RORC (0.49) | ALDH1A1TDP1CYP3A4ALOX15MPO | |
| SCHEMBL29928895 | 0.87 | ALDH1A1 (0.48) | ALDH1A1TDP1CYP3A4ALOX15MPO | |
| SCHEMBL28275431 | 0.85 | ALDH1A1 (0.55) | ALDH1A1TDP1CYP3A4ALOX15MPO | |
| SCHEMBL16045437 | 0.83 | L3MBTL1 (0.60) | ALDH1A1TDP1CYP3A4ALOX15MAPT | |
| SCHEMBL2152528 | 0.83 | ALDH1A1 (0.48) | ALDH1A1TDP1MPOMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119757578-A | Detection method and preparation method of nitenpyram impurity | 安徽贝克制药股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-118281338-A | F & NO-containing material2Methyl benzoate electrolyte, lithium ion battery and preparation method thereof | 电子科技大学 | 2024-07-02 | — | — | CN | claimed |
| CN-113880762-B | Triacylamine derivatives containing 1,8-naphthalimide as well as preparation method and application thereof | 河北农业大学 | 2023-02-21 | — | — | CN | claimed |
| CN-113880762-A | 1, 8-naphthalimide-containing triacylamine derivatives, and preparation method and application thereof | 河北农业大学 | 2022-01-04 | — | — | CN | claimed |
| CN-111725408-A | Quantum dot light-emitting diode, preparation method thereof and composite material | TCL集团股份有限公司 | 2020-09-29 | — | — | CN | claimed |
| EP-4430042-B1 | 6-HETERO ARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS | AJAX THERAPEUTICS INC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12440494-B2 | Compounds useful for inhibiting RAF dimers | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2025-10-14 | — | — | US | disclosed |
| US-12410281-B2 | Diamine compound, polyimide precursor and polyimide film using the same, and use thereof | SK INNOVATION CO., LTD. (KR) | 2025-09-09 | — | — | US | disclosed |
| US-20250223299-A1 | MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE | REGENERON PHARMACEUTICALS, INC. | 2025-07-10 | — | — | US | disclosed |
| US-12297207-B2 | Maytansinoid derivatives, conjugates thereof, and methods of use | REGENERON PHARMACEUTICALS, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-12275717-B2 | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors | AJAX THERAPEUTICS, INC. (US) | 2025-04-15 | — | — | US | disclosed |
| CN-119757578-A | Detection method and preparation method of nitenpyram impurity | 安徽贝克制药股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-20020151595-A1 | Carboxylic acid amides having antithrombotic activity | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-10-17 | — | — | US | disclosed |
| CN-1359403-A | Diaminobenzene derivative, polyimide obtained therefrom, and liquid crystal alignment film | NISSAN CHEMICAL IND LTD (JP) | 2002-07-17 | — | — | CN | disclosed |
| EP-1209185-A1 | DIAMINOBENZENE DERIVATIVE, POLYIMIDE OBTAINED THEREFROM, AND LIQUID-CRYSTAL ALIGNMENT FILM | Nissan Chemical Industries, Ltd. (JP) | 2002-05-29 | — | — | EP | disclosed |
| US-5187167-A | Antitumor agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-02-16 | — | — | US | disclosed |
| US-5081124-A | Amino acid and polyamino acid derivatives, inhibitors of thymidylate synthetase | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-01-14 | — | — | US | disclosed |
| EP-0239362-B1 | ANTI-TUMOR AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-12-04 | — | — | EP | disclosed |
| US-4992550-A | Thymidylate synthetase inhibitors | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-02-12 | — | — | US | disclosed |
| EP-0239362-A2 | Anti-tumor agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12275717-B2 | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors | JAK2, JAK3, STAT5B | ALDH1A1 3735/4885TDP1 3813/4885CYP3A4 2677/4885 |
| US-20250223299-A1 | MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE | SLC10A1, HNMT, OGFR | ALDH1A1 317/4885TDP1 1130/4885CYP3A4 1529/4885 |
| US-12297207-B2 | Maytansinoid derivatives, conjugates thereof, and methods of use | SLC10A1, HNMT, OGFR | ALDH1A1 317/4885TDP1 1130/4885CYP3A4 1529/4885 |
| US-12410281-B2 | Diamine compound, polyimide precursor and polyimide film using the same, and use thereof | PUF60, PARG, DDT | ALDH1A1 1920/4885TDP1 817/4885CYP3A4 4754/4885 |
| US-12440494-B2 | Compounds useful for inhibiting RAF dimers | BRAF, RAF1, NRAS | ALDH1A1 880/4885TDP1 1623/4885CYP3A4 3301/4885 |
| US-20020151595-A1 | Carboxylic acid amides having antithrombotic activity | SERPINC1, TFPI, F2 | ALDH1A1 112/4885TDP1 1476/4885CYP3A4 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.